Early research (Phase 1)Study completedNCT02503358
What this trial is testing
Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Who this might be right for
Stage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7
OHSU Knight Cancer Institute 23